About
Dr Benjamin Elyan is an Honorary Clinical Lecturer at the University of Glasgow's School of Cardiovascular & Metabolic Health. His research focuses on cardiovascular data science, kidney disease coding/analysis, and cardio-oncology. He leads projects investigating cancer incidence in chronic kidney disease (CKD) patients, drug safety of VEGF inhibitors/immune checkpoint inhibitors, and sex differences in cancer outcomes among CKD populations. His work integrates large-scale healthcare data to inform clinical decision-making and improve patient outcomes.
Key research themes include:
- Chronic kidney disease progression and comorbidities
- Cancer-CKD interface in epidemiology and treatment outcomes
- Cardiovascular safety of oncology therapies
- Data-driven approaches in nephrology
Recent publications highlight:
- Systematic reviews/meta-analyses on CKD-cancer interactions
- Nationwide registry analyses of dialysis populations
- Retrospective drug safety studies
- Cardiovascular trial design evaluations
No specific awards or grants are listed in the provided information. Collaborations involve multidisciplinary teams from nephrology, oncology, and cardiology fields.
Find Benjamin Elyan elsewhere
Related Searches
You Might Also Like
- KKaitlin MayneUniversity of Glasgow · Academic
- PPatrick MarkUniversity of Glasgow · Professor
- DDemetrios VlahakosEuropean University Cyprus · Visiting Professor
- KKeith GillisUniversity of Glasgow · Senior Lecturer
- SStephen RankinUniversity of Glasgow · Academic
- SSokratis StoumposUniversity of Glasgow · Senior Lecturer